Cargando…
Outcomes From Whole-Brain Reirradiation Using Pulsed Reduced Dose Rate Radiation Therapy
PURPOSE: Recurrent intracranial metastases after whole-brain irradiation pose a clinical challenge owing to the escalating morbidity associated with their treatment. Although stereotactic radiosurgery is increasingly being used, there are still situations in which whole-brain reirradiation (ReRT) co...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557211/ https://www.ncbi.nlm.nih.gov/pubmed/33083645 http://dx.doi.org/10.1016/j.adro.2020.06.021 |
_version_ | 1783594370049507328 |
---|---|
author | Burr, Adam R. Robins, Henry Ian Bayliss, Robert Adam Baschnagel, Andrew M. Welsh, James S. Tomé, Wolfgang A. Howard, Steven P. |
author_facet | Burr, Adam R. Robins, Henry Ian Bayliss, Robert Adam Baschnagel, Andrew M. Welsh, James S. Tomé, Wolfgang A. Howard, Steven P. |
author_sort | Burr, Adam R. |
collection | PubMed |
description | PURPOSE: Recurrent intracranial metastases after whole-brain irradiation pose a clinical challenge owing to the escalating morbidity associated with their treatment. Although stereotactic radiosurgery is increasingly being used, there are still situations in which whole-brain reirradiation (ReRT) continues to be appropriate. Here, we report our experience using whole-brain pulsed reduced dose rate radiation therapy (PRDR), a method that delivers radiation at a slower rate of 0.067 Gy/min to potentially increase sublethal damage repair and decrease toxicity. METHODS AND MATERIALS: Patients undergoing whole-brain ReRT with PRDR from January 1, 2001 to March 2019 were analyzed. The median PRDR ReRT dose was 26 Gy in 2 Gy fractions, resulting in a median total whole-brain dose of 59.5 Gy. Cox regression analysis was used for multivariate analysis. The Kaplan-Meier method was used for overall survival, progression free survival, and to evaluate the ReRT score. Binary logistic regression was employed to evaluate variables associated with rapid death. RESULTS: Seventy-five patients were treated with whole-brain PRDR radiation therapy. The median age was 54 (range, 26-72), the median Karnofsky performance status (KPS) was 80, and 86.7% had recursive partitioning analysis scores of 2. Thirty-two patients had over 10 metastases and 11 had leptomeningeal disease. The median overall survival was 4.1 months (range, 0.29-59.5 months) with a 1 year overall survival of 10.4%. Age, KPS, dexamethasone usage, and intracranial disease volume were significantly correlated with overall survival on multivariate analysis. A KPS ≤70 was associated with rapid death after radiation. The prognostic value of the ReRT score was validated. The most common acute toxicities were fatigue (23.1%) and headache (16.9%). CONCLUSIONS: In this large cohort of patients with advanced intracranial metastases, PRDR achieves acceptable survival and may decrease toxicity associated with ReRT. PRDR is an easily implemented technique and is a viable treatment option for ReRT of brain metastases. |
format | Online Article Text |
id | pubmed-7557211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-75572112020-10-19 Outcomes From Whole-Brain Reirradiation Using Pulsed Reduced Dose Rate Radiation Therapy Burr, Adam R. Robins, Henry Ian Bayliss, Robert Adam Baschnagel, Andrew M. Welsh, James S. Tomé, Wolfgang A. Howard, Steven P. Adv Radiat Oncol Scientific Article PURPOSE: Recurrent intracranial metastases after whole-brain irradiation pose a clinical challenge owing to the escalating morbidity associated with their treatment. Although stereotactic radiosurgery is increasingly being used, there are still situations in which whole-brain reirradiation (ReRT) continues to be appropriate. Here, we report our experience using whole-brain pulsed reduced dose rate radiation therapy (PRDR), a method that delivers radiation at a slower rate of 0.067 Gy/min to potentially increase sublethal damage repair and decrease toxicity. METHODS AND MATERIALS: Patients undergoing whole-brain ReRT with PRDR from January 1, 2001 to March 2019 were analyzed. The median PRDR ReRT dose was 26 Gy in 2 Gy fractions, resulting in a median total whole-brain dose of 59.5 Gy. Cox regression analysis was used for multivariate analysis. The Kaplan-Meier method was used for overall survival, progression free survival, and to evaluate the ReRT score. Binary logistic regression was employed to evaluate variables associated with rapid death. RESULTS: Seventy-five patients were treated with whole-brain PRDR radiation therapy. The median age was 54 (range, 26-72), the median Karnofsky performance status (KPS) was 80, and 86.7% had recursive partitioning analysis scores of 2. Thirty-two patients had over 10 metastases and 11 had leptomeningeal disease. The median overall survival was 4.1 months (range, 0.29-59.5 months) with a 1 year overall survival of 10.4%. Age, KPS, dexamethasone usage, and intracranial disease volume were significantly correlated with overall survival on multivariate analysis. A KPS ≤70 was associated with rapid death after radiation. The prognostic value of the ReRT score was validated. The most common acute toxicities were fatigue (23.1%) and headache (16.9%). CONCLUSIONS: In this large cohort of patients with advanced intracranial metastases, PRDR achieves acceptable survival and may decrease toxicity associated with ReRT. PRDR is an easily implemented technique and is a viable treatment option for ReRT of brain metastases. Elsevier 2020-07-08 /pmc/articles/PMC7557211/ /pubmed/33083645 http://dx.doi.org/10.1016/j.adro.2020.06.021 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Scientific Article Burr, Adam R. Robins, Henry Ian Bayliss, Robert Adam Baschnagel, Andrew M. Welsh, James S. Tomé, Wolfgang A. Howard, Steven P. Outcomes From Whole-Brain Reirradiation Using Pulsed Reduced Dose Rate Radiation Therapy |
title | Outcomes From Whole-Brain Reirradiation Using Pulsed Reduced Dose Rate Radiation Therapy |
title_full | Outcomes From Whole-Brain Reirradiation Using Pulsed Reduced Dose Rate Radiation Therapy |
title_fullStr | Outcomes From Whole-Brain Reirradiation Using Pulsed Reduced Dose Rate Radiation Therapy |
title_full_unstemmed | Outcomes From Whole-Brain Reirradiation Using Pulsed Reduced Dose Rate Radiation Therapy |
title_short | Outcomes From Whole-Brain Reirradiation Using Pulsed Reduced Dose Rate Radiation Therapy |
title_sort | outcomes from whole-brain reirradiation using pulsed reduced dose rate radiation therapy |
topic | Scientific Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557211/ https://www.ncbi.nlm.nih.gov/pubmed/33083645 http://dx.doi.org/10.1016/j.adro.2020.06.021 |
work_keys_str_mv | AT burradamr outcomesfromwholebrainreirradiationusingpulsedreduceddoserateradiationtherapy AT robinshenryian outcomesfromwholebrainreirradiationusingpulsedreduceddoserateradiationtherapy AT baylissrobertadam outcomesfromwholebrainreirradiationusingpulsedreduceddoserateradiationtherapy AT baschnagelandrewm outcomesfromwholebrainreirradiationusingpulsedreduceddoserateradiationtherapy AT welshjamess outcomesfromwholebrainreirradiationusingpulsedreduceddoserateradiationtherapy AT tomewolfganga outcomesfromwholebrainreirradiationusingpulsedreduceddoserateradiationtherapy AT howardstevenp outcomesfromwholebrainreirradiationusingpulsedreduceddoserateradiationtherapy |